Read + Share
de Botton S, Montesinos P, Schuh AC, Papayannidis C, et al. Enasidenib vs conventional care in older patients with late-stage mutant-IDH2
relapsed/refractory AML: a randomized phase 3 trial. Blood 2023;141:156-167.
PMID: 35714312
|
 |
|
de Botton S, Montesinos P, Schuh AC, Papayannidis C, et al. Enasidenib vs conventional care in older patients with late-stage mutant-IDH2
relapsed/refractory AML: a randomized phase 3 trial. Blood 2023;141:156-167.
PMID: 35714312
|
|
|
|